HELIOS is a Phase II trial evaluating the safety, tolerability and effects of AMX0035 in adults with Wolfram syndrome.

One of the most important lessons I've learned is that changing your mind doesn’t signal weakness—it shows growth and ...

Wolfram Alpha has come a long way from just helping teens do calculus. These useful, surprising features can help you in your ...

The past few days have been very pleasant for biotech company Amylyx Pharmaceuticals (NASDAQ: AMLX). As is often the case ...

Easton Wolfram netted two goals as Lakeside Lutheran's boys soccer team closed the regular season by beating visiting ...

Amylyx ...

Climate change has a negative impact on food security. An international research team led by Wolfram Weckwerth from the ...

Climate change has a negative impact on food security. Researchers have now conducted a study to investigate the natural ...

EQ Resources has secured $250,000 from the Queensland government to hold advanced x-ray transmission ore sorting trials at the historical Wolfram Camp in the ...

A new study highlights the potential of chickpeas to bolster food security, showcasing their drought resistance and high ...

Several area athletes competed in the Top of Iowa Conference cross country championships in Mason City on Thursday.

马萨诸塞州剑桥 - Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) 宣布其针对成年Wolfram综合征患者的AMX0035 Phase 2 HELIOS试验取得积极的初步结果。Wolfram综合征是一种罕见且进行性的疾病。该试验显示，在24周的治疗期内，胰腺功能（一项关键的疾病进展指标）有所改善。